Health, Wealth and Medicines for All? Regulating the Pharmaceutical Industry for Community Benefit

A discussion of the issues relating to the public's sometimes conflicting interest in the efficient, low-cost provision of medicines and support of a strong, profitable and innovative pharmaceutical industry. This publication also provides the necessary background to the Pharmaceutical Price Regulation Scheme and other supply and demand side developments in spending and use, with a concluding analysis of the future of medicines regulation in the UK and the EU in the light of the major review of medicines licensing due to take place in 2001.